Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Italy issues warning letter to Pfizer due to COVID vaccine delays, Reuters says » 15:19
01/25/21
01/25
15:19
01/25/21
15:19
PFE

Pfizer

$37.10 /

+0.555 (+1.52%)

The Italian government…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.10 /

+0.555 (+1.52%)

PFE Pfizer
$37.10 /

+0.555 (+1.52%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
PFE Pfizer
$37.10 /

+0.555 (+1.52%)

PFE Pfizer
$37.10 /

+0.555 (+1.52%)

PFE Pfizer
$37.10 /

+0.555 (+1.52%)

PFE Pfizer
$37.10 /

+0.555 (+1.52%)

Hot Stocks
BioNTech, Shanghai Fosun receive Hong Kong approval for Covid vaccine » 12:22
01/25/21
01/25
12:22
01/25/21
12:22
BNTX

BioNTech

$108.58 /

+0.29 (+0.27%)

, SFOSF

Shanghai Fosun

$0.00 /

+ (+0.00%)

BioNTech (BNTX) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BNTX BioNTech
$108.58 /

+0.29 (+0.27%)

BNTX BioNTech
$108.58 /

+0.29 (+0.27%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
12/15/20 Jefferies
Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play'
SFOSF Shanghai Fosun
$0.00 /

+ (+0.00%)

BNTX BioNTech
$108.58 /

+0.29 (+0.27%)

  • 23
    Jul
  • 06
    Feb
BNTX BioNTech
$108.58 /

+0.29 (+0.27%)

BNTX BioNTech
$108.58 /

+0.29 (+0.27%)

BNTX BioNTech
$108.58 /

+0.29 (+0.27%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:18
01/25/21
01/25
12:18
01/25/21
12:18
MRK

Merck

$80.68 /

-0.28 (-0.35%)

, GME

GameStop

$95.00 /

+30.27 (+46.76%)

, MRNA

Moderna

$142.70 /

+11.65 (+8.89%)

, PFE

Pfizer

$36.94 /

+0.395 (+1.08%)

, NCR

NCR Corp.

$33.98 /

+0.56 (+1.68%)

, CATM

Cardtronics

$38.50 /

-2.4 (-5.87%)

, APO

Apollo Global

$46.02 /

-0.445 (-0.96%)

, BBBY

Bed Bath & Beyond

$34.03 /

+3.8 (+12.57%)

, BB

BlackBerry

$18.62 /

+4.59 (+32.72%)

, SOL

ReneSola

$26.72 /

-6.92 (-20.57%)

, MGNI

Magnite

$36.91 /

-3.175 (-7.92%)

The major averages are…

ShowHide Related Items >><<
SOL ReneSola
$26.72 /

-6.92 (-20.57%)

PFE Pfizer
$36.94 /

+0.395 (+1.08%)

NCR NCR Corp.
$33.98 /

+0.56 (+1.68%)

MRNA Moderna
$142.70 /

+11.65 (+8.89%)

MRK Merck
$80.68 /

-0.28 (-0.35%)

MGNI Magnite
$36.91 /

-3.175 (-7.92%)

GME GameStop
$95.00 /

+30.27 (+46.76%)

CATM Cardtronics
$38.50 /

-2.4 (-5.87%)

BBBY Bed Bath & Beyond
$34.03 /

+3.8 (+12.57%)

BB BlackBerry
$18.62 /

+4.59 (+32.72%)

APO Apollo Global
$46.02 /

-0.445 (-0.96%)

MRK Merck
$80.68 /

-0.28 (-0.35%)

01/21/21 Wedbush
Scholar Rock price target raised to $66 from $47 at Wedbush
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
01/20/21 Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
01/06/21 Citi
Citi opens 'positive catalyst watch' on Merck
GME GameStop
$95.00 /

+30.27 (+46.76%)

09:52 Today
Fly Intel: Top five analyst downgrades
08:57 Today Telsey Advisory
GameStop continues surge despite double downgrade at Telsey Advisory
05:37 Today Telsey Advisory
GameStop downgraded to Underperform from Outperform at Telsey Advisory
01/13/21 Standpoint Research
GameStop downgraded to Hold from Buy at Standpoint Research
MRNA Moderna
$142.70 /

+11.65 (+8.89%)

09:47 Today Piper Sandler
Piper reiterates $170 target on Moderna with vaccine active on new strains
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/06/21 Piper Sandler
Moderna price target raised to $170 after EU vaccine approval at Piper Sandler
01/04/21 Piper Sandler
Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler
PFE Pfizer
$36.94 /

+0.395 (+1.08%)

01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
NCR NCR Corp.
$33.98 /

+0.56 (+1.68%)

01/11/21 Wells Fargo
Wells Fargo not ruling out counter-bid for Cardtronics slightly higher than $39
01/11/21 JPMorgan
NCR bid for Cardtronics makes sense, says JPMorgan
01/11/21 Stephens
NCR Corp. price target raised to $49 from $39 at Stephens
12/14/20 Craig-Hallum
Par Technology price target raised to $75 from $55 at Craig-Hallum
CATM Cardtronics
$38.50 /

-2.4 (-5.87%)

11:00 Today Truist
Cardtronics downgraded to Hold from Buy at Truist
APO Apollo Global
$46.02 /

-0.445 (-0.96%)

01/20/21 Truist
Athene Holding price target raised to $55 from $48 at Truist
01/11/21 Wells Fargo
Apollo Global price target raised to $55 from $50 at Wells Fargo
12/18/20 Deutsche Bank
Apollo Global price target raised to $51 from $49 at Deutsche Bank
11/06/20
Fly Intel: Top five analyst upgrades
BBBY Bed Bath & Beyond
$34.03 /

+3.8 (+12.57%)

07:22 Today Loop Capital
Bed Bath & Beyond price target raised to $30 from $18 at Loop Capital
01/08/21 Wedbush
Bed Bath & Beyond Q3 results 'mixed,' says Wedbush
01/08/21 Baird
Bed Bath & Beyond elevated to Fresh Pick at Baird
01/05/21 Baird
Bed Bath & Beyond Q3 expectations remain low, says Baird
BB BlackBerry
$18.62 /

+4.59 (+32.72%)

12/18/20 TD Securities
BlackBerry price target raised to $8.50 from $5.50 at TD Securities
12/15/20 RBC Capital
BlackBerry price target raised to $7.50 from $5 at RBC Capital
12/15/20 RBC Capital
BlackBerry price target raised to $7.50 from $5.00 at RBC Capital
12/01/20 TD Securities
BlackBerry jump on AWS pact looks like overreaction, says TD Securities
SOL ReneSola
$26.72 /

-6.92 (-20.57%)

12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
12/14/20 H.C. Wainwright
ReneSola price target raised to $12 from $4 at H.C. Wainwright
09/17/20 H.C. Wainwright
ReneSola initiated with a Buy at H.C. Wainwright
03/03/20
LD Micro to hold a virtual conference
MGNI Magnite
$36.91 /

-3.175 (-7.92%)

01/24/21 Truist
Magnite downgraded to Hold from Buy at Truist
01/22/21 Craig-Hallum
Magnite price target raised to $45 from $25 at Craig-Hallum
01/11/21 Susquehanna
Magnite weakness a buying opportunity, says Susquehanna
12/21/20 Needham
Magnite price target raised to $30 from $18 at Needham
SOL ReneSola
$26.72 /

-6.92 (-20.57%)

PFE Pfizer
$36.94 /

+0.395 (+1.08%)

NCR NCR Corp.
$33.98 /

+0.56 (+1.68%)

MRNA Moderna
$142.70 /

+11.65 (+8.89%)

MRK Merck
$80.68 /

-0.28 (-0.35%)

MGNI Magnite
$36.91 /

-3.175 (-7.92%)

GME GameStop
$95.00 /

+30.27 (+46.76%)

CATM Cardtronics
$38.50 /

-2.4 (-5.87%)

BBBY Bed Bath & Beyond
$34.03 /

+3.8 (+12.57%)

BB BlackBerry
$18.62 /

+4.59 (+32.72%)

APO Apollo Global
$46.02 /

-0.445 (-0.96%)

  • 19
    May
  • 12
    Feb
PFE Pfizer
$36.94 /

+0.395 (+1.08%)

NCR NCR Corp.
$33.98 /

+0.56 (+1.68%)

MRNA Moderna
$142.70 /

+11.65 (+8.89%)

MRK Merck
$80.68 /

-0.28 (-0.35%)

MGNI Magnite
$36.91 /

-3.175 (-7.92%)

GME GameStop
$95.00 /

+30.27 (+46.76%)

BBBY Bed Bath & Beyond
$34.03 /

+3.8 (+12.57%)

BB BlackBerry
$18.62 /

+4.59 (+32.72%)

APO Apollo Global
$46.02 /

-0.445 (-0.96%)

SOL ReneSola
$26.72 /

-6.92 (-20.57%)

PFE Pfizer
$36.94 /

+0.395 (+1.08%)

NCR NCR Corp.
$33.98 /

+0.56 (+1.68%)

MRNA Moderna
$142.70 /

+11.65 (+8.89%)

MRK Merck
$80.68 /

-0.28 (-0.35%)

MGNI Magnite
$36.91 /

-3.175 (-7.92%)

GME GameStop
$95.00 /

+30.27 (+46.76%)

CATM Cardtronics
$38.50 /

-2.4 (-5.87%)

BBBY Bed Bath & Beyond
$34.03 /

+3.8 (+12.57%)

BB BlackBerry
$18.62 /

+4.59 (+32.72%)

APO Apollo Global
$46.02 /

-0.445 (-0.96%)

SOL ReneSola
$26.72 /

-6.92 (-20.57%)

PFE Pfizer
$36.94 /

+0.395 (+1.08%)

MRNA Moderna
$142.70 /

+11.65 (+8.89%)

MRK Merck
$80.68 /

-0.28 (-0.35%)

MGNI Magnite
$36.91 /

-3.175 (-7.92%)

GME GameStop
$95.00 /

+30.27 (+46.76%)

BBBY Bed Bath & Beyond
$34.03 /

+3.8 (+12.57%)

BB BlackBerry
$18.62 /

+4.59 (+32.72%)

APO Apollo Global
$46.02 /

-0.445 (-0.96%)

Options
Pfizer call volume above normal and directionally bullish » 12:05
01/25/21
01/25
12:05
01/25/21
12:05
PFE

Pfizer

$36.93 /

+0.39 (+1.07%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.93 /

+0.39 (+1.07%)

PFE Pfizer
$36.93 /

+0.39 (+1.07%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
PFE Pfizer
$36.93 /

+0.39 (+1.07%)

PFE Pfizer
$36.93 /

+0.39 (+1.07%)

PFE Pfizer
$36.93 /

+0.39 (+1.07%)

PFE Pfizer
$36.93 /

+0.39 (+1.07%)

Hot Stocks
Pfizer, Merck KGaA announce EC approval of Bavencio for UC patients » 09:19
01/25/21
01/25
09:19
01/25/21
09:19
PFE

Pfizer

$36.54 /

+0.05 (+0.14%)

, MKGAY

Merck KGaA

$0.00 /

+ (+0.00%)

Earlier, EMD Serono, the…

Earlier, EMD Serono, the Healthcare business sector of Merck KGaA (MKGAY) and Pfizer (PFE) announced that the European Commission has approved Bavencio as monotherapy for the first-line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma, or UC, who are progression-free following platinum-based chemotherapy. Bavencio was first approved in the U.S. as a first-line maintenance treatment for advanced UC by the U.S. Food and Drug Administration in June 2020 and is now approved for this indication in 38 countries, the companies said. Additional regulatory applications are under review in 13 countries, including in Japan, where approval is expected in H1 2021.

ShowHide Related Items >><<
PFE Pfizer
$36.54 /

+0.05 (+0.14%)

MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.54 /

+0.05 (+0.14%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

01/04/21 JPMorgan
Merck KGaA upgraded to Overweight from Neutral at JPMorgan
11/20/20 Pareto
Merck KGaA upgraded to Buy from Hold at Pareto
11/16/20 AlphaValue
Merck KGaA upgraded to Add from Reduce at AlphaValue
10/13/20 Barclays
Merck KGaA upgraded to Equal Weight from Underweight at Barclays
PFE Pfizer
$36.54 /

+0.05 (+0.14%)

PFE Pfizer
$36.54 /

+0.05 (+0.14%)

MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.54 /

+0.05 (+0.14%)

PFE Pfizer
$36.54 /

+0.05 (+0.14%)

Periodicals
Pfizer to ship fewer vaccine vials to fulfill commitment to U.S., NY Times says » 08:37
01/25/21
01/25
08:37
01/25/21
08:37
PFE

Pfizer

$36.54 /

+0.05 (+0.14%)

Pfizer will be shipping…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$36.54 /

+0.05 (+0.14%)

PFE Pfizer
$36.54 /

+0.05 (+0.14%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
PFE Pfizer
$36.54 /

+0.05 (+0.14%)

PFE Pfizer
$36.54 /

+0.05 (+0.14%)

PFE Pfizer
$36.54 /

+0.05 (+0.14%)

PFE Pfizer
$36.54 /

+0.05 (+0.14%)

Friday
Hot Stocks
Pfizer, BioNTech reach agreement with COVAX for advance purchase of vaccine » 12:02
01/22/21
01/22
12:02
01/22/21
12:02
PFE

Pfizer

$36.47 /

-0.02 (-0.05%)

, BNTX

BioNTech

$106.21 /

+0.87 (+0.83%)

Pfizer (PFE) and BioNTech…

Pfizer (PFE) and BioNTech (BNTX) announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021. COVAX is a global initiative coordinated by the Global Alliance for Vaccines and Immunization, the Coalition for Epidemic Preparedness Innovations and the World Health Organization, to ensure equitable access to COVID-19 vaccines for all countries, regardless of income levels. COVAX includes an Advanced Market Commitment financial mechanism that aims to ensure that 92 low- and lower-middle-income countries will be able to secure access to COVID-19 vaccines at the same time as higher-income countries. The first doses are expected to be delivered in the first quarter of 2021, subject to the negotiation and execution of supply agreements under the COVAX Facility structure. For the COVAX Advanced Market Commitment 92 countries, Pfizer and BioNTech will provide the vaccine to COVAX at a not-for-profit price. Financial terms of the agreement were not disclosed.

ShowHide Related Items >><<
PFE Pfizer
$36.47 /

-0.02 (-0.05%)

BNTX BioNTech
$106.21 /

+0.87 (+0.83%)

PFE Pfizer
$36.47 /

-0.02 (-0.05%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
BNTX BioNTech
$106.21 /

+0.87 (+0.83%)

12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
12/15/20 Jefferies
Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play'
PFE Pfizer
$36.47 /

-0.02 (-0.05%)

BNTX BioNTech
$106.21 /

+0.87 (+0.83%)

  • 23
    Jul
  • 06
    Feb
PFE Pfizer
$36.47 /

-0.02 (-0.05%)

BNTX BioNTech
$106.21 /

+0.87 (+0.83%)

PFE Pfizer
$36.47 /

-0.02 (-0.05%)

BNTX BioNTech
$106.21 /

+0.87 (+0.83%)

PFE Pfizer
$36.47 /

-0.02 (-0.05%)

BNTX BioNTech
$106.21 /

+0.87 (+0.83%)

Hot Stocks
Coty promotes Stephane Delbos to chief procurement officer » 08:20
01/22/21
01/22
08:20
01/22/21
08:20
COTY

Coty

$6.88 /

-0.01 (-0.15%)

, PFE

Pfizer

$36.49 /

+0.01 (+0.03%)

Coty (COTY) announced the…

Coty (COTY) announced the promotion of Stephane Delbos to chief procurement officer, or CPO, effective February 1. Delbos, who joined Coty in 2010 as global sourcing director, has been promoted from his current role as senior VP for transformation, indirect and procurement operations, where he has played an important role in driving forward Coty's broader transformation agenda. Delbos will join Coty's senior leadership team and report to Gordon von Bretten, chief transformation officer. Delbos is a senior procurement professional with over 18 years' experience in the beauty and pharmaceutical industries. Prior to joining Coty, he held several local and global procurement positions at Pfizer (PFE). In his new role, Delbos will be responsible for implementing Coty's multi-year procurement strategy, which includes achieving a significant cost reduction target by FY23, reducing complexity and strengthening Coty's new product pipeline. This forms an important element of Coty's transformation program, announced in 2020.

ShowHide Related Items >><<
PFE Pfizer
$36.49 /

+0.01 (+0.03%)

COTY Coty
$6.88 /

-0.01 (-0.15%)

COTY Coty
$6.88 /

-0.01 (-0.15%)

12/07/20 Wells Fargo
Coty downgraded to Underweight from Equal Weight at Wells Fargo
11/19/20
Fly Intel: Top five analyst upgrades
11/19/20 Citi
Coty upgraded to Buy from Neutral at Citi
11/09/20 Deutsche Bank
Coty price target raised to $6 from $4 at Deutsche Bank
PFE Pfizer
$36.49 /

+0.01 (+0.03%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
PFE Pfizer
$36.49 /

+0.01 (+0.03%)

COTY Coty
$6.88 /

-0.01 (-0.15%)

PFE Pfizer
$36.49 /

+0.01 (+0.03%)

PFE Pfizer
$36.49 /

+0.01 (+0.03%)

COTY Coty
$6.88 /

-0.01 (-0.15%)

PFE Pfizer
$36.49 /

+0.01 (+0.03%)

COTY Coty
$6.88 /

-0.01 (-0.15%)

Thursday
Hot Stocks
ViiV Healthcare announces FDA approval of Cabenuva » 16:46
01/21/21
01/21
16:46
01/21/21
16:46
GSK

GlaxoSmithKline

$37.79 /

-0.23 (-0.60%)

, PFE

Pfizer

$36.49 /

+0.01 (+0.03%)

, JNJ

Johnson & Johnson

$161.69 /

-0.71 (-0.44%)

ViiV Healthcare, the…

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline (GSK), with Pfizer (PFE) and Shionogi Limited as shareholders, announced that the U.S. FDA approved Cabenuva, the first and only complete long-acting regimen for the treatment of HIV-1 infection in adults. Cabenuva is provided as a co-pack with two injectable medicines, ViiV Healthcare's cabotegravir and Janssen's (JNJ) rilpivirine, dosed once monthly, as an option to replace the current antiretroviral regimen in those who are virologically suppressed on a stable regimen, with no history of treatment failure, and with no known or suspected resistance to either cabotegravir or rilpivirine. Prior to initiating treatment of Cabenuva, oral dosing of cabotegravir and rilpivirine should be administered for approximately one month to assess the tolerability of each therapy.

ShowHide Related Items >><<
PFE Pfizer
$36.49 /

+0.01 (+0.03%)

JNJ Johnson & Johnson
$161.69 /

-0.71 (-0.44%)

GSK GlaxoSmithKline
$37.79 /

-0.23 (-0.60%)

GSK GlaxoSmithKline
$37.79 /

-0.23 (-0.60%)

01/20/21 UBS
GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS
01/20/21
Fly Intel: Top five analyst downgrades
01/20/21 Credit Suisse
GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse
01/20/21 Credit Suisse
GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse
PFE Pfizer
$36.49 /

+0.01 (+0.03%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
JNJ Johnson & Johnson
$161.69 /

-0.71 (-0.44%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
PFE Pfizer
$36.49 /

+0.01 (+0.03%)

JNJ Johnson & Johnson
$161.69 /

-0.71 (-0.44%)

GSK GlaxoSmithKline
$37.79 /

-0.23 (-0.60%)

PFE Pfizer
$36.49 /

+0.01 (+0.03%)

JNJ Johnson & Johnson
$161.69 /

-0.71 (-0.44%)

GSK GlaxoSmithKline
$37.79 /

-0.23 (-0.60%)

PFE Pfizer
$36.49 /

+0.01 (+0.03%)

JNJ Johnson & Johnson
$161.69 /

-0.71 (-0.44%)

GSK GlaxoSmithKline
$37.79 /

-0.23 (-0.60%)

PFE Pfizer
$36.49 /

+0.01 (+0.03%)

JNJ Johnson & Johnson
$161.69 /

-0.71 (-0.44%)

GSK GlaxoSmithKline
$37.79 /

-0.23 (-0.60%)

Periodicals
Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports » 15:21
01/21/21
01/21
15:21
01/21/21
15:21
PFE

Pfizer

$36.45 /

-0.035 (-0.10%)

, BNTX

BioNTech

$107.01 /

+3.71 (+3.59%)

Pfizer (PFE) has cut in…

Pfizer (PFE) has cut in half the volume of COVID-19 vaccines it will deliver to some EU countries this week, Reuters' Radu-Sorin Marinas, Jan Lopatka, and Tsvetelia Tsolova report, citing government officials. Pfizer and its partner BioNTech (BNTX) have declined to comment on the cuts beyond their statement last week, the report noted. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

PFE Pfizer
$36.45 /

-0.035 (-0.10%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
12/15/20 Jefferies
Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play'
PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

  • 23
    Jul
  • 06
    Feb
PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

PFE Pfizer
$36.45 /

-0.035 (-0.10%)

BNTX BioNTech
$107.01 /

+3.71 (+3.59%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.